Bayer stock slips 0.39% to EUR 56.34 before Xetra
Published on 11/13/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Bayer Investors Should Watch
- The premarket indication is below Thursday's Xetra close.
- Bayer operates across Pharmaceuticals, Consumer Health and Crop Science.
- Its Pharmaceuticals business includes prescription products and specialty therapies.
Bayer stock traded at EUR 56.34 on Lang & Schwarz at 08:30:41 CET on Friday, November 13, 2026, 0.39 percent below the Xetra close of Thursday, November 12, at EUR 56.56.
Bayer's business spans three main areas: Pharmaceuticals, Consumer Health and Crop Science. Its prescription-drug operations cover cardiology, women's health, oncology, hematology, ophthalmology, diagnostic imaging and other specialty therapies. Consumer Health sells over-the-counter products and supplements, while Crop Science supplies crop protection products, seeds, digital farming solutions and related services.
For investors, the portfolio combines healthcare exposure with agricultural markets. The Pharmaceuticals segment remains central to the company's life science profile, while Consumer Health and Crop Science provide additional business lines across global end markets. The Bayer company profile identifies these three operating segments.
The broader German market is represented by the DAX, the relevant domestic benchmark for the stock's trading environment.
